98 related articles for article (PubMed ID: 6659019)
1. Sample preparation and estimation of plasma concentration of 3-deazauridine by high-performance liquid chromatography.
Lin KT; Momparler RL; Rivard GE
Ther Drug Monit; 1983; 5(4):491-6. PubMed ID: 6659019
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and disposition of 3-deazauridine in humans.
Benvenuto JA; Hall SW; Farquhar D; Stewart DJ; Benjamin RS; Loo TL
Cancer Res; 1979 Feb; 39(2 Pt 1):349-52. PubMed ID: 761206
[TBL] [Abstract][Full Text] [Related]
3. Transport of uridine and 3-deazauridine in cultured human lymphoblastoid cells.
Dahlig-Harley E; Paterson AR; Robins MJ; Cass CE
Cancer Res; 1984 Jan; 44(1):161-5. PubMed ID: 6580947
[TBL] [Abstract][Full Text] [Related]
4. High-pressure liquid chromatographic analysis of 3-deazauridine-5'-triphosphate in human cancer cells.
Plunkett W; Benvenuto JA; Stewart DJ; Loo TL
Cancer Treat Rep; 1979 Mar; 63(3):415-20. PubMed ID: 284846
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography.
Plunkett W; Chubb S; Barlogie B
J Chromatogr; 1980 Dec; 221(2):425-30. PubMed ID: 6938519
[No Abstract] [Full Text] [Related]
6. Adaptation of solid phase extraction to an automated column switching method for online sample cleanup as the basis of a facile and sensitive high-performance liquid chromatographic assay for paclitaxel in human plasma.
Supko JG; Nair RV; Seiden MV; Lu H
J Pharm Biomed Anal; 1999 Dec; 21(5):1025-36. PubMed ID: 10703971
[TBL] [Abstract][Full Text] [Related]
7. Determination of 5-fluorouracil and its main metabolites in plasma by high-performance liquid chromatography.
Barberi-Heyob M; Merlin JL; Webér B
J Chromatogr; 1992 Jan; 573(2):247-52. PubMed ID: 1534812
[TBL] [Abstract][Full Text] [Related]
8. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
Moriconi WJ; Slavik M; Taylor S
Invest New Drugs; 1986; 4(1):67-84. PubMed ID: 2422137
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic analysis of 5-ethylpyrimidines and 5-methylpyrimidines in plasma.
Joly JM; Williams WM
J Chromatogr; 1991 Feb; 563(2):392-9. PubMed ID: 1878072
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial and pharmacokinetics of a daily x 5 schedule of 3-deazauridine.
Creaven PJ; Priore RL; Mittelman A; Bruno S; Henderson ES; Rustum YM; Solomon JK
Cancer Treat Rep; 1982 Jan; 66(1):81-4. PubMed ID: 7053271
[TBL] [Abstract][Full Text] [Related]
11. Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid.
Stewart DJ; Benvenuto JA; Leavens M; Hall SW; Benjamin RS; Plunkett W; McCredie KB; Burgess MA; Loo TL
Cancer Res; 1979 Oct; 39(10):4119-22. PubMed ID: 476649
[TBL] [Abstract][Full Text] [Related]
12. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
Grant S; Cadman E
Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541
[TBL] [Abstract][Full Text] [Related]
13. The disposition of 3-deazauridine in mice.
Cysyk RL; Gormley PE; D'Anna ME; Adamson RH
Drug Metab Dispos; 1978; 6(2):125-32. PubMed ID: 26526
[No Abstract] [Full Text] [Related]
14. Quantification of tipranavir in human plasma by high-performance liquid chromatography with UV detection.
Giraud E; Rey E; Tréluyer JM; Pons G; Jullien V
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):86-90. PubMed ID: 16260190
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazole.
Frank SK; Mathiesen DA; Whitfield LR; Ames MM
J Chromatogr; 1987 Aug; 419():225-32. PubMed ID: 3667780
[TBL] [Abstract][Full Text] [Related]
16. An efficient HPLC method for the quantitative determination of atazanavir in human plasma suitable for bioequivalence and pharmacokinetic studies in healthy human subjects.
Müller AC; Kanfer I
J Pharm Biomed Anal; 2010 Sep; 53(1):113-8. PubMed ID: 20395105
[TBL] [Abstract][Full Text] [Related]
17. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
Karle JM; Cysyk RL
Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous analysis of disopyramide and quinidine in plasma by high-performance liquid chromatography.
Ahokas JT; Davies C; Ravenscroft PJ
J Chromatogr; 1980 Jul; 183(1):65-71. PubMed ID: 7400265
[TBL] [Abstract][Full Text] [Related]
19. Phase I--II study of 3-deazauridine in adults with acute leukemia.
Yap BS; McCredie KB; Keating MJ; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(5-6):521-4. PubMed ID: 7237473
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
